Short answerProtocol amendments are now the norm: Tufts CSDD found 82% of Phase III protocols had at least one substantial amendment between 2018 and 2021, averaging 3.5 each. Implementation takes about 260 days end to end, and each amendment means reconsent, retraining, IRB work, and budget changes at the site. Sites recover the cost by pricing amendment work in the original budget and renegotiating when visits or procedures change.
How common are amendments?
- 82% of Phase III protocols had at least one substantial amendment in 2018 to 2021, up from 66% in 2013 to 2015, and the average rose from 2.3 to 3.5 per protocol (Tufts CSDD via Clinical Trial Vanguard).
- In earlier Tufts research, nearly half (45%) of substantial amendments were judged avoidable (Tufts CSDD).
What do amendments cost?
- Sponsors: a median direct cost of $141,000 per substantial amendment on a Phase II protocol and $535,000 on Phase III (Tufts CSDD).
- Time: about 260 days from final internal approval to the last required ethics approval, and 89 days to the first patient reconsented (Applied Clinical Trials). Protocols with a substantial amendment take about three unplanned months longer to complete (Tufts CSDD).
- Version confusion: sites operate on different protocol versions for a mean of 215 days during an amendment cycle (IntuitionLabs, citing Tufts CSDD).
What does an amendment cost the site?
- Reviewing the new protocol and updating source documents and SOPs.
- IRB submission and new consent forms.
- Reconsenting every active participant.
- Retraining staff, and updating pharmacy procedures.
- Delays that push back visits, and therefore payments (Bourne Partners).
How do sites get paid for amendments?
- Price amendments in the original budget. Published institutional fees include $500 per protocol amendment with consent changes and $250 without (LSU Health), and up to $1,618 per pharmacy amendment (Johns Hopkins).
- Add reconsent visits as invoiceable per patient items.
- Renegotiate the visit grid whenever the amendment adds visits or procedures.
- Track your actual hours per amendment so the next budget is evidence based.
See invoiceables sites forget to bill.
What about enrollment during an amendment?
Many amendments loosen eligibility. When they do, sites that already have referral relationships can tell physicians about the change the week it is approved, and turn a broader protocol into new patients quickly instead of waiting for them to appear.
Get your study in front of the right local physicians
TrialNotice builds a physician referral pipeline around one active study. We identify relevant local physicians within driving distance of your site, send study aligned direct mail, follow up by email and LinkedIn, track engagement with recipient level QR codes, and route warm responses into your site team's workflow.
Talk to TrialNoticeSources
- Clinical Trial Vanguard, "Tufts CSDD: New Insights on The Clinical Trial Industry" (SCOPE 2024)
- Getz K. et al., "The Impact of Protocol Amendments on Clinical Trial Performance and Cost," Therapeutic Innovation & Regulatory Science (Tufts CSDD)
- Applied Clinical Trials, "Shining a Light on the Inefficiencies in Amendment Implementation" (Tufts CSDD)
- Applied Clinical Trials, "Acknowledging Cycle Time Impact from Protocol Amendments" (Tufts CSDD)
- IntuitionLabs, "Clinical Trial Protocol Amendments: Frequency, Cost and Delay Data" (citing Tufts CSDD)
- LSU Health New Orleans Clinical Trials Office, Budget Development training
- Johns Hopkins School of Medicine, Standard Costs and Fees for Sponsored Clinical Trials (FY2024)
- Bourne Partners, "Update on the Fundamentals of Clinical Trial Sites" (SCRS Global Site Solutions Summit takeaways, October 2025)
